Filing Flows › 8-K events › iQSTEL
iQSTEL: entry into a material definitive agreement
Form 8-K filed Oct 26, 2026 · items 1.01, 2.03, 3.02, 8.01
Share offeringsIQST - IQSTEL Closes Two-Year Non-Convertible Financing for Ultranet, a Profitable $131 Million-Revenue West African Telecom Platform Expected to Make IQSTEL Cash-Flow Positive on a Consolidated Basis
What the filing says
On October 20, 2026, iQSTEL Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with M2B Funding Corp. (“M2B”) and ADI Funding LLC (“ADI,” and together with M2B, the “Purchasers”). Pursuant to the Purchase Agreement, the Company issued and sold to each Purchaser a senior secured
ScaleThe filing names $131.0M: about 30% of iQSTEL's annual revenue ($436.3M, four times the latest quarter).
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 2.03: 0.0% next session across 13,268. Item 3.02: +0.1% next session across 2,750. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.
iQSTEL at a glance
iQSTEL, Q2 2026: revenue $109M (+51% year over year), operating margin -1.0%. The chart follows the revenue to costs, profit and cash.
iQSTEL: every quarter, Q/Q and Y/Y, holders and guidance →
Other recent share offerings
- Airsculpt Technologies Nov 6, 2026
- Biovie Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Nextnrg Nov 6, 2026
- Paid Nov 6, 2026
- Silo Pharma Nov 6, 2026
- Agility Robotics Nov 6, 2026
- American Healthcare REIT Nov 6, 2026
- Entera Bio Nov 6, 2026
- Janus Living Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.